Published in
American Society for Clinical Investigation, Journal of Clinical Investigation, 4(129), p. 1596-1611, 2019
DOI: 10.1172/jci98785
Links
Tools
Targeting compensatory MEK/ERK activation increases JAK inhibitor efficacy in myeloproliferative neoplasms
Journal article published in 2019 by
Simona Stivala 
,
Tamara Codilupi ,
Sime Brkic,
Anne Baerenwaldt,
Nilabh Ghosh,
Hui Hao-Shen,
Stephan Dirnhofer,
Matthias S. Dettmer ,
Cedric Simillion ,
Beat A. Kaufmann ,
Sophia Chiu ,
Matthew Keller,
Maria Kleppe,
Morgane Hilpert,
Andreas S. Buser
and other authors.
,
Tamara Codilupi ,
Sime Brkic,
Anne Baerenwaldt,
Nilabh Ghosh,
Hui Hao-Shen,
Stephan Dirnhofer,
Matthias S. Dettmer ,
Cedric Simillion ,
Beat A. Kaufmann ,
Sophia Chiu ,
Matthew Keller,
Maria Kleppe,
Morgane Hilpert,
Andreas S. Buser
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 